25 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd.
11 Sep 24
Notice of Annual General Meeting of Shareholders
8:30am
. (Nasdaq: ZIO), and previously held several senior leadership roles at Bayer AG and LEO Pharma. The majority of Dr. Schwartz’s achievements have been
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd.
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
), and previously held several senior leadership roles at Bayer AG and LEO Pharma. The majority of Dr. Schwartz’s achievements have been in oncology
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd.
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
to ArQule, Dr. Schwartz was CMO at ZIOPHARM Oncology Inc. (Nasdaq: ZIO), and previously held several senior leadership roles at Bayer AG and LEO … leadership of these financing efforts was particularly important when considering the decline in stock prices of small-cap biotech stocks in 2021
6-K
EX-99.1
lyhtp0f6
23 May 22
Enlivex Appoints Dr. Roger J. Pomerantz to its Board of Directors as Vice Chairman
8:03am
6-K
EX-99.1
r9dpi8
22 Nov 21
Enlivex Announces Third Quarter 2021 Financial Results and Provides a Business Update
8:00am
6-K
EX-99.1
3m7ssl8j
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-99.1
0kc0pyxn1q1f9z6dgiw
9 Aug 21
Enlivex Announces Second Quarter 2021 Financial Results and Provides a Business Update
8:00am
6-K
EX-99.1
m5e9r7od
1 Mar 21
Report of Foreign Private Issuer
7:58am
6-K
e7r74iux
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
02l45 jo7
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
r72oj992ok 0f5
9 Oct 15
Appoints Former Aptalis and Novartis Executive, Theresa M. Stevens, as Chief Corporate Development Officer
12:00am